Skip to main content

Table 3 Genotype distribution of NF-κB binding site SNPs with ESRD cases and control group

From: Investigation of the variants at the binding site of inflammatory transcription factor NF-κB in patients with end-stage renal disease

SNPs

Control (N = 847)

ESRD (N = 847)

Crude-OR (95% CI)

p-value

Adj-OR (95% CI) a

p-value

rs11826681C/G

   

0.385

 

0.251

CC

304 (35.9%)

288 (34.3%)

1.00

 

1.00

 

CG

421 (49.7%)

418 (48.9%)

1.03 (0.83–1.27)

0.798

1.00 (0.81–1.25)

0.970

GG

122 (14.4%)

141 (16.8%)

1.22 (0.91–1.63)

0.181

1.26 (0.94–1.70)

0.128

rs17036427G/C

   

0.825

 

0.826

GG

723 (85.4%)

718 (84.8%)

1.00

 

1.00

 

GC

119 (14.0%)

122 (14.4%)

1.03 (0.79–1.36)

0.819

1.00 (0.75–1.32)

0.990

CC

5 (0.6%)

7 (0.8%)

1.41 (0.45–4.46)

0.559

1.44 (0.45–4.63)

 

rs59118205C/T

   

0.624

 

0.905

CC

745 (88.0%)

753 (89.0%)

1.00

 

1.00

 

TC

98 (11.6%)

92 (10.8%)

0.92 (0.68–1.24)

0.583

0.93 (0.68–1.27)

0.935

TT

4 (0.5%)

2 (0.2%)

0.49 (0.09–2.71)

0.417

1.09 (0.15–7.87)

0.662

rs7284245G/T

   

0.234

 

0.220

GG

611 (72.3%)

582 (69.5%)

1.00

 

1.00

 

GT

211 (25.0%)

247 (28.4%)

1.18 (0.95–1.47)

0.127

1.15 (0.92–1.44)

0.210

TT

23 (2.7%)

18 (2.1%)

0.82 (0.44–1.54)

0.539

0.70 (0.36–1.34)

0.278

rs7651075G/A

   

0.104

 

0.139

GG

219 (25.9%)

185 (22.0%)

1.00

 

1.00

 

AG

398 (46.9%)

440 (51.5%)

1.29 (1.02–1.64)

0.036

1.26 (0.99–1.61)

0.062

AA

230 (27.2%)

222 (26.4%)

1.14 (0.87–1.50)

0.331

0.12 (0.85–1.48)

0.417

rs77836284C/T

   

0.775

 

0.662

CC

703 (83.8%)

709 (84.4%)

1.00

 

1.00

 

TC

133 (14.9%)

130 (14.6%)

0.98 (0.74–1.28)

0.858

1.03 (0.78–1.36)

0.856

TT

11 (1.3%)

8 (1.0%)

0.72 (0.29–1.80)

0.484

0.65 (0.25–1.70)

0.378

rs78229468A/G

   

0.518

 

0.719

AA

697 (82.4%)

696 (82.3%)

1.00

 

1.00

 

GA

146 (17.1%)

143 (16.8%)

0.98 (0.76–1.26)

0.881

0.98 (0.75–1.27)

0.859

GG

4 (0.5%)

8 (0.9%)

2.00 (0.60–6.68)

0.258

1.65 (0.47–5.74)

0.432

rs79143300G/T

   

0.668

 

0.464

GG

737 (87.0%)

731 (86.3%)

1.00

 

1.00

 

GT

105 (12.4%)

113 (13.3%)

1.09 (0.82–1.44)

0.574

1.11 (0.83–1.49)

0.471

TT

5 (0.6%)

3 (0.4%)

0.60 (0.14–2.54)

0.492

0.43 (0.08–2.26)

0.321

rs9395890G/T

   

0.031*

 

0.049*

GG

153 (18.1%)

138 (16.4%)

1.00

 

1.00

 

GT

419 (49.5%)

379 (45.1%)

1.00 (0.77 to 1.31)

0.983

0.98 (0.75 to 1.29)

0.110

TT

274 (32.4%)

324 (38.5%)

1.31 (0.99 to 1.74)

0.059

1.26 (0.95 to 1.68)

0.908

rs9925427A/G

   

0.902

 

0.826

AA

638 (77.2%)

665 (79.1%)

1.00

 

1.00

 

GA

208 (22.7%)

192 (20.9%)

0.95 (0.75–1.20)

0.650

0.93 (0.73–1.18)

0.537

GG

1

0

0.00 (0.00 - inf)

0.969

0.00 (0.00-inf)

0.969

  1. *p < 0.05
  2. a: adjust: gender, age, BMI, Hypertension, DM